Live Breaking News & Updates on Infection At Two Community

Stay updated with breaking news from Infection at two community. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals

/PRNewswire/ Today, LumiraDx (Nasdaq: LMDX) a next-generation point of care (POC) diagnostics company announced that the intended use for its Food and Drug. ....

United Kingdom , United States , Pima County , City Of , Nigel Lindner , Colleen Mcmillen , Amerj Clin , Pharmacy Inc , Testing At Two University Campuses , Drug Administration , Melinda Gates Foundation , National Health Service , Infection At Two Community , Exchange Commission , University Of Washington , Global Health , Emergency Use Authorization , Lumiradx Chief Innovation Officer , Paul Drain , South America , Federal Food , Cosmetic Act , Securities Litigation Reform Act , Proxy Statement , Antigen Test , Two Community Based Testing Sites ,

LumiraDx Announces the Intended Use for its FDA EUA Authorized High Sensitivity COVID-19 Antigen Test has been Expanded to Include Testing of Asymptomatic Individuals

- Microfluidic immunofluorescence assay authorized for screening asymptomatic individuals using a single test with results available in 12 minutes - The test performance for viral antigen ....

United Kingdom , United States , Pima County , City Of , Nigel Lindner , Colleen Mcmillen , Amerj Clin , Pharmacy Inc , Testing At Two University Campuses , Drug Administration , Melinda Gates Foundation , National Health Service , Infection At Two Community , Exchange Commission , University Of Washington , Departments Of Global Health , American Journal , Clinical Pathology , Emergency Use Authorization , Lumiradx Chief Innovation Officer , Paul Drain , Global Health , South America , Federal Food , Cosmetic Act , Lumiradx Platform ,